Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)

NCT01571128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1215

Last updated 2022-02-18

No results posted yet for this study

Summary

MP3 Youth is a pilot study to evaluate the feasibility and acceptability of a gender-specific combination HIV prevention package for youth (aged 15-24) in high burden settings. The study aims to pilot a combination package of gender-specific interventions in western Kenya in a mobile health delivery format using integrated services delivery.

Conditions

  • HIV
  • Adolescent Behavior
  • Gender

Interventions

OTHER

Male-Specific Intervention Package

Combination HIV Prevention: Male-Specific Intervention Package at the Mobile Health events and longitudinal follow up of cohorts.

OTHER

Female-Specific Intervention Package

Combination HIV Prevention: Female-Specific Intervention Package at the Mobile Health events and longitudinal follow up of cohorts.

DRUG

Pre-Exposure Prophylaxis (Females)

Females 18-24 who are out of school.

BEHAVIORAL

Cash Transfer Cohort (Females)

Cash transfer for females (and their parents) who are aged 15-24 and enrolled in school.

Sponsors & Collaborators

  • University of Nairobi

    collaborator OTHER
  • Impact Research & Development Organization

    collaborator OTHER
  • New York University

    lead OTHER

Principal Investigators

  • Irene Inwani, MD, MPH · Kenyatta National Hospital: University of Nairobi, Kenya

  • Ann Kurth, PhD, CNM · New York University

  • Jasmine Buttolph, MPH · New York University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-03-23
Completion
2016-03-23

Countries

  • United States
  • Kenya

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571128 on ClinicalTrials.gov